+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Kidney Stone Drug"

From
Urolithiasis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Urolithiasis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Kidney Stone Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. These drugs are used to treat kidney stones, which are small, hard deposits of minerals and salts that form in the kidneys. They can cause pain, infection, and other complications. Common treatments for kidney stones include medications, surgery, and dietary changes. The drugs used to treat kidney stones are typically diuretics, antispasmodics, and alpha-blockers. The Kidney Stone Drug market is highly competitive, with many companies offering a variety of products. Companies in the market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, Novartis, and Sanofi. These companies offer a range of products, from generic drugs to branded medications. Additionally, many of these companies have research and development programs to develop new treatments for kidney stones. Show Less Read more